Latest Australian Market News

IPH Limited reported a 16.9% jump in net profit to $80.4 million for FY26, driven by strong Canadian growth and operational discipline, alongside a new CEO appointment and its inaugural sustainability report.

Yowie Group's revenue declined in the first half of 2026 as it navigated supply chain shifts and cautious retail demand, but the company secured a significant Australian licensing deal and ended costly legacy litigation.

OceanaGold is set to acquire Ausgold and its Katanning Gold Project for A$776 million, adding a promising low-capital open-pit development in Western Australia with production expected in 2029.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

oOh!media reported a 1.4% revenue increase to $340.9 million in 1H26 but saw adjusted underlying EBITDA fall 22.5% due to rising fixed rents and soft billboard demand. The company declared a 2 cent interim dividend and agreed to a $1.68 per share takeover scheme with I Squared Capital.

Freightways reported a solid FY26 with 13.5% revenue growth to NZD 1.46 billion and a 17.3% rise in net profit, underpinned by strong Australian market gains and operational efficiencies despite economic headwinds.

Ainsworth Game Technology has locked in a critical patent licence agreement with Aristocrat, granting rights to key gaming features and responsible gaming technologies in Australia while settling past patent disputes.

Austco Healthcare has completed the $2.24 million acquisition of Medical Communications Systems, transitioning its long-term South Australian reseller into a direct sales operation to deepen market engagement.

Noodlecake Studios, under Streamplay Studio Limited, has secured a publishing agreement with Brazilian developer Mango Salad Games for the PC game Harpooner, marking its entry into Latin America and adding a shorter-cycle title to its portfolio.

EROAD has appointed David Leach as CEO, effective October 2026, aiming to leverage his SaaS scaling expertise to accelerate growth and develop an AI-native platform.

Centrepoint Alliance reported a 16% rise in normalised EBITDA to $12.3 million for FY26, exceeding its guidance and lifting its EBITDA margin to 29%. The company’s adviser network grew modestly, while funds under management jumped 48%.

Clarity Pharmaceuticals bolsters its commercial readiness with a $178.3 million cash reserve and a key US manufacturing agreement, while clinical trials for its prostate cancer imaging and therapeutic agents progress with promising data.